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Abstract 
Due to their high specificity against target antigens, monoclonal antibodies (mAbs) 
have proven to be a very powerful tool for diagnostic and therapeutic purpose against 
several diseases. Currently there are over 26 mAb approved for therapeutic use by 
the FDA. The manufacture of mAbs is a complex process where purification plays a 
key role. This project proposes and simulates a purification process based on an 
array of chromatographic columns. The different employed columns were modelled 
by kinetic dispersive models using parameters from available bibliography as well as 
some assumptions. The proposed method consists of five columns connected in 
series and offered arguably good results with a purity and yield of the target mAb 
of~90% and ~85% respectively. 
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Summary 
Monoclonal antibodies are a group of molecules with growing interest in the 
pharmaceutical industry. The different variations of this biomolecules are capable of 
identifying and binding to a wide variety of targets such as viruses, cancer cells or 
other agents causing diseases. This makes monoclonal antibodies a very powerful 
tool for diagnosis and therapy of diseases. 
One of the critical steps in the manufacture of monoclonal antibodies is the 
purification process. The purpose of this work is to define a purification process and 
simulate it to predict the expected results. 
In order to purify the target antibody it must be separated from the impurities present 
in the initial solution, which is achieved by using chromatographic columns which 
retain the different components more or less time depending on physical and 
chemical interactions, this means that some components will leave the column earlier 
while others will take longer allowing us the separate the target antibody from the 
impurities. 
These different columns separate the components on the basis of their different 
charge, affinity to bind to a biomolecule and the different size of the components. 
The simulated purification process consists of five different columns connected in 
series where the outflow of one column continuously feeds the next one.  
This simulation showed promising results as over 90% purity was reached with a high 
yield of product and there is margin to refine the process. 
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1. Introduction 
1.1. Aim 
The aim of this work is to define, model and simulate a method of purification of monoclonal 
immunoglobulin G (IgG). The entire process is to be based on chromatographic methods and 
the solution is expected to produce a good yield of IgG with high purity. 
1.2. Immunoglobulin G 
Antibodies or immunoglobulin are Y-shaped proteins which form part of the immune system. 
Their role is to identify and neutralize pathogens. They are rather big proteins with a 
molecular weight that can be estimated to 150kDa.  
All the immunoglobulins have a common structure with two identical heavy chains and two 
identical light chains. A disulphide bond, binds each light chain with one of the heavy chains, 
the heavy chains are also joint together by disulphide bonds [1]. 
The molecule can be divided into two fragments, the Fab-fragments which contains variable 
region of the light chains and the heavy chains, and the Fc-fragment. 
The tip at the end of the heavy and light chains in the Fab-fragment combine to form two 
identical antigen binding sites, this is the part of the antibody that binds to the target antigen. 
This variable region allows for many possibilities thus the immune system is capable identify 
a wide range of antigens due to the great diversity of antibodies. The part of the antigen where 
the antibody binds is named epitope [1]. 
Depending on the heavy chains of the antibody they can be classified into isotypes. The 
isotype which is object of this study is IgG. This immunoglobulin is the most abundant 
antibody found in humans and they are generated by plasma cells. 
 
Figure 1 Immunoglobulin G structure 
The purpose of this project is purifying monoclonal IgG. Monoclonal antibodies (mAbs) are 
those who are made by identical immune cells. The distinct feature of mAbs is that they have 
affinity to a single antigen this means they can target disease causing organism with high 
selectivity. This means different mAbs can be used to treat or diagnose a wide range of 
diseases such as cancer or auto immune diseases. 
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1.2.1. Aggregation 
Protein aggregation is a phenomenon that occurs during the different steps of protein 
production and affects the quality, safety and efficacy of the product. The mechanism of 
aggregation is poorly understood [2]. These aggregates appear initially as dimers and then 
grow into larger structures. 
The difference between the biological activity between the aggregates and the monomeric 
protein can significantly affect the potency of the protein based drug [3]. Also proteins 
aggregates can result in immune responses to the therapeutic product. [4]. 
There are no defined limits for the maximum allowable aggregate levels in protein-based 
drugs since the effect of these aggregates on final product depends on the product itself. The 
only limitation described in the US pharmacopeia and European pharmacopeia refers to sub-
visible particles “Solutions for injection must be clear and practically free from particles”. [2] 
Therefore those limits must be specified for each product drug. 
As they are proteins mAbs also suffer from aggregation. Aggregates can form during the 
various steps of monoclonal antibody manufacturing processes. 
1.2.1.1. Aggregation during cell culture 
Cell culture is the step where cells are grown to produce target molecule. Aggregation in this 
step is a common phenomenon; the aggregate levels during this step for monoclonal 
antibodies have been reported up to 30% in some cases [6]. 
1.2.1.2. Aggregates during purification 
In order to purify monoclonal antibodies they go through a variety of steps based on different 
methods: this incur in variations of pH, ionic strength, concentration but the proteins also 
suffer mechanical stresses and are in contact with different materials. All of this has different 
effects on protein aggregation. 
 pH conditions: A widely used step in antibody purification is protein A 
chromatography. This method requires a low pH. At low pH proteins might undergo 
structural changes that could contribute to product aggregation [7]. 
Another during the antibody purification that requires low pH is the virus inactivation 
step. 
 Salt buffers: Salt buffers have complex effects on protein stability. Depending on the 
concentration, salt type and ionic strength this might have a stabilizing or destabilizing 
effect on the protein. 
 Agitation also increases the effect of aggregation. 
 Pumping: During the purification of the antibodies the use of pumps is quite 
extensive especially in steps that require flow control such as chromatography [2]. 
This leads to mechanical stresses that might enhance the effect of protein aggregation. 
 Ultrafiltration, Final filling, Freeze-Thaw and Storage: During the last steps of the 
manufacture aggregation might also occur and since the aggregates are to be removed 
in the previous purification steps it’s important to reduce the formation of aggregates 
in these last steps. 
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1.2.1.3. Aggregate removal by means of chromatography 
Chromatography is the mean by which aggregates are to be removed. The first 
chromatographic column in the antibody purification process is normally an affinity 
chromatography column. This step is not capable of removing aggregates since they might 
bind to the column similarly to antibody. 
The methods that have been demonstrated useful for the removal of aggregates are anionic 
and cationic ion exchange [2]. 
As the aggregates form bigger molecules than the monomer, size exclusion chromatography 
might also be a valid method for the removal of aggregates, but it is considered inefficient due 
the poor resolution of aggregates from the monomer. [8]. 
It is also possible to separate aggregates based on hydrophobicity using hydrophobic 
interaction chromatography methods, as the hydrophobicity of the antibody molecules 
increases with aggregation [2]. 
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2. Separation methods 
2.1. Non-chromatographic methods 
Even though, the process described in this work is based entirely in chromatographic methods 
it might also be worth mentioning the trends in the different non-chromatographic methods 
that are employed in antibody purification processes. 
2.1.1. Precipitation 
Monoclonal antibodies can be purified by precipitation; this process is based on the addition 
of polyethylene glycol (PEG) and ammonium sulphate to separate the mAb from the liquid 
phase. This is an interesting method since it concentrating an antibody with such a method 
offers the best volume reduction any purification method can offer. 
This process is used in lab-scale purification of IgG from bovine, human serum and 
mammalian cell culture supernatants [9]. 
2.1.2. Liquid-Liquid extraction 
Liquid-Liquid extraction is a technique based on transferring objective antibody from one 
solvent into another. This method can be used as IgG has a tendency to transfer from an 
aqueous solutions into a hydrophobic PEG-rich phase, this can achieve a purity of IgG up to 
70-95% and a yield of IgG higher than 95% [9]. 
2.1.3. High performance tangential flow filtration 
A method proposed by van Reis [10] consist on a charged ultrafiltration (100-300kDa) that 
can be used to purify IgG in acidic conditions, the proposed membrane would repel the 
positively charged IgG even if it were able to pass the membrane. 
2.2. Chromatographic methods 
2.2.1. Fluidized bed and fixed bed chromatography 
In a fluidized bed chromatography the particles are dispersed in a liquid medium as opposed 
to fixed bed chromatography. Operation of fluidized bed is more complex than that of fixed 
bed but it has the benefit that it allows the purification from unclarified feed stocks such as the 
cell culture media or fermentation broths [11]. 
On the other hand fixed bed chromatography remains the most widely used method [9]. 
Applications are normally run with a single bed whose dimensions can be increased if more 
capacity is required. These report simulated fixed be chromatography columns as these are 
less complex systems and it was assumed that the feed stock was previously clarified. 
2.2.2. Size exclusion chromatography 
Size exclusion is purification method based on the different size on the molecules to be 
separated. A size exclusion column is filled with porous particles of a determined pore size, 
which means that if the pore size is small enough it should allow separating molecules 
between those big enough to fit into the pores and those that cannot enter them. The smaller 
particles will diffuse through more space into the column and therefore will have a higher 
retention time. 
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Since monoclonal antibodies such as IgG have large molecular weight (about 150kDa) size 
exclusion is an effective method to separate these particles from smaller impurities. The 
problem with the size exclusion method is that since it is not an adsorption based method the 
productivity is low, and feed volumes are also required to be low >4%(column volume)[12] in 
order to produce effective separation. 
Due to the different size nature of antibodies and its aggregates it could be expected that size 
exclusion (SEC) would be a good method to separate them but this process offers low 
productivity [9] and resolution [8]. 
In this project however, size exclusion chromatography columns are used in the purification 
process in order to increase the pH after the protein A column and to reduce the salt content 
after the Ion exchange column. 
2.2.3. Anionic ion exchange chromatography 
Depending on the product to be purified anionic ion exchange (AIEX) column can be run two 
different modes. For example Murine IgGs are run in bind-elute mode since good binding 
conditions can be achieved at pH 8-8.5 , for Human and chimeric IgGs flow-through mode is 
used instead since they do not bind to the column[9]. 
In this project anionic ion exchange was used as the last step in flow-through mode in order to 
eliminate the remaining aggregate concentration, as the aggregates were assumed to bind 
more strongly to the column. 
2.2.4. Cationic ion exchange chromatography 
Antibodies have a relatively high isoelectric point that means they are protonated and have a 
positive charge at not to low pH values.  For that reason cationic ion exchange is (CIEX) 
normally used in bind-elute mode. 
In industrial antibody manufacture processes, cationic ion exchange is a commonly used 
method as a second purification step following protein A affinity chromatography [12]. 
In order to enhance the elution, salt gradients are the most commonly used, but elution by 
means of pH gradients are also possible, or even a combination of both. 
In this project the process flow was driven through a cationic ion exchange column after an 
affinity chromatography column and a size exclusion column to settle the pH. 
2.2.5. Hydrophobic interaction chromatography 
As opposite to the other chromatographic methods based on adsorption, hydrophobic 
interaction chromatography (HIC) is entropically driven [12] and is used to separate the 
antibody from its aggregate forms based on hydrophobicity as the aggregate forms are more 
hydrophobic. This method is not used in the setup studied at this work as an AIEX column is 
used as a final step to remove the aggregates instead of HIC column. 
2.2.6. Affinity chromatography 
Affinity chromatography separates proteins on the basis of interaction between proteins and a 
specific ligand linked to the chromatographic matrix.  It can be used as long as a suitable 
ligand is available for the protein. 
The target protein is bound to a complementary substance, the ligand. The material which is 
not bound is washed away and once that is done the conditions are changed to enhance 
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desorption, by changes in pH, ionic strength or polarity. In this project, desorption is 
enhanced by a pH reduction. 
In order to purify IgG both Protein A and Protein G based columns can be used as IgG is able 
to bind to both, in this Protein A affinity column was modelled as it is the most widely used. 
However this method is not effective when separating antibodies from its aggregates or 
fragments containing the Fab region. 
2.3. Proposed purification setup 
The setup studied consisted of a series of chromatography columns, in this setup the process 
flow is run continuously from a column to the next which means that the product from a 
column is the fed into the next column without an intermediate mixing step. 
The purification consists of five steps; all of them based on chromatographic methods, and 
can be seen in the following picture. 
Protein A Affinity
Size exclusion 
Cationic Ion 
exchange
Size exclusion
Anionic ion 
exchange
 
Figure 2 Process setup 
The first step is an affinity chromatography column; this column is feed with the fresh feed 
containing the solution of IgG. It is assumed to be previously clarified so there are not cell 
debris and lipids present. 
The column is expected to efficiently separate the IgG from impurities but not from the 
aggregates. It runs in bind-elute mode which means that the feed is loaded with binding 
conditions i.e. pH 5 and then the eluting is driven by decreasing the pH which leads to worse 
binding of the molecules to the column and the elution of these. 
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The affinity chromatography column is followed by a size exclusion column, the purpose of 
which is to stabilize the pH so that the following cationic ion exchange column is not fed with 
an acidic pH gradient. This is important since the binding on the molecules to the cationic ion 
exchange column depends not only on the salt concentration but also on the pH. 
In normal manufacturing processes a virus deactivation step follows the affinity 
chromatography. In the virus deactivation the process flow is held during residence times 
longer than an hour at acidic conditions (pH~3). This virus simulation step can be 
implemented in the size exclusion step as long as the residence time at low pH is equal to at 
least one hour. 
The third step is a cationic ion exchange column; this column further increases the separation 
of the components, allowing higher purity of the product IgG or better yield. This column also 
runs in bind-elute mode which means that the feed from the previous column first to bind to 
the column, and then start eluding when a salt gradient is applied. 
The forth step is another size exclusion column the purpose of which is to reduce the salt 
concentration at the outlet of the cationic ion exchange. This is done by means of a size 
exclusion column as the salt ions are expected to elute later than the product due to their much 
smaller particle size. 
The last step is an anionic ion exchange column running in flow-through mode where the 
aggregates and impurities are expected to bind to the column and elute later than the product. 
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3. Theory and mathematical modelling 
There were five components modelled in this project, these are: 
 IgG: The monoclonal antibody to be purified 
 Aggregates: Dimers and other oligomers formed by IgG aggregation. Note that effect 
of aggregation during the purification process was not modelled, instead an initial 
quantity of aggregates was assumed to be loaded at the start of the purification process 
that had to be removed. 
 Other impurities: The other impurities present, were modelled as a single component. 
 Na+: Salt ions that form the salt buffer used in the CIEX column. 
 H+: pH was modelled as the concentration of H+ ions 
All the mathematical models were based on the dispersion model for packed beds and are in 
the form of: 
𝜕𝐶
𝜕𝑡
= 𝐷𝑎𝑥𝑝
𝜕2𝐶
𝜕𝑧2
−
𝑣
𝜀𝑇
𝜕𝐶
𝜕𝑧
−
1−𝜀𝑇
𝜀𝑇
𝜕𝑞
𝜕𝑡
       (1) 
Equation (1) takes into account the effect of dispersion, convection and adsorption. The 
adsorption term and the convection term are calculated differently for each column. But the 
dispersion is calculated the same way in all the cases. 
This dispersion term corresponds to: 
𝐷𝑎𝑥𝑝
𝜕2𝐶
𝜕𝑧2
          (2) 
In order to include this dispersion term into the simulation the apparent dispersion coefficient 
must be known. This was calculated based on 
𝐷𝑎𝑥𝑝 =
𝑣·𝐿
𝑃𝑒
          (3) 
The characteristic length 𝐿 in a packed bed is the particle diameter, Peclet number was 
assumed to be 𝑃𝑒~0.35 for all the columns. 
Therefore apparent axial dispersion could be calculated as equation 4 shows: 
𝐷𝑎𝑥𝑝 =
𝑣·𝑑𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝑠
0.35
         (4) 
The total porosity 𝜀𝑇 is defined as 
𝜀𝑇 = 𝜀𝑐 + (1 − 𝜀𝑐) · 𝜀𝑃        (5) 
Where 𝜀𝑐 is the column porosity and 𝜀𝑃 is the packing porosity. 
  
9 
 
3.1. Affinity Chromatography 
The affinity chromatography column separates the target IgG from the impurities based on 
their affinity to protein A. The binding of IgG to the chromatographic column is modified by 
the pH value. 
This method is not effective in order to separate the antibody from its aggregates, as both are 
expected to bind similarly to the column. Also the low pH inside the affinity column might 
enhance the effect of aggregation however this effect is not modelled. 
3.1.1. Affinity Chromatography Model 
In order to simulate the affinity chromatography column a transport-dispersive model 
proposed by Candy K.S and others [13] was used. This model is a lumped parameter model 
that considers diffusion which is often the rate-limiting step in protein separation [14, 15]. 
The model used is a dispersion model that assumes homogeneity in the radial axis, isothermal 
adsorption and lumped coefficients for axial dispersion and mass transfer resistances [16]. 
The employed kinetic equation for the column can be described as: 
𝜕𝐶
𝜕𝑡
= 𝐷𝑎𝑥𝑝
𝜕2𝐶
𝜕𝑧2
−
𝑣
𝜀𝑇
𝜕𝐶
𝜕𝑧
−
1−𝜀𝑇
𝜀𝑇
𝜕𝑞
𝜕𝑡
       (6) 
𝜕𝑞
𝜕𝑡
= 𝑘𝑚(𝑞
∗ − 𝑞)         (7) 
The mass transfer coefficient was to be calculated following the empirical correlation: 
𝑘𝑚 = 𝑘𝑚𝑎𝑥 [𝑆1 + (1 − 𝑆1) (1 −
𝑞𝑅
𝑞𝑚𝑎𝑥,𝑅
)
𝑆2
]      (8) 
In order to calculate the absorption isotherm two different approaches were taken into 
consideration. 
For the target component IgG and the aggregates, it was defined as a Langmuir adsorption 
isotherm with pH as a modifier: 
𝑞𝑖𝑔𝐺
∗ =
𝑞𝑚𝑎𝑥·𝐾𝐴·(
𝑝𝐻
𝑝𝐻𝑟𝑒𝑓
)
𝑛
𝐶𝐼𝑔𝐺
1+𝐾𝐴·(
𝑝𝐻
𝑝𝐻𝑟𝑒𝑓
)
𝑛
𝐶𝐼𝑔𝐺
        (9) 
However for the impurities a linear adsorption isotherm is considered instead: 
𝑞𝑖𝑚𝑝
∗ = 𝐻 · 𝐶𝑖𝑚𝑝         (10) 
The boundary conditions were defined as a no-flux boundary condition on the right end 
eq.(11) of the column and a Dirichlet condition on the other end eq.(11) where the 
concentration in that boundary is set to the concentration of the feed to the column. 
𝐶|𝑍=0 = 𝐶𝑓𝑒𝑒𝑑         (11) 
𝜕𝐶
𝜕𝑡
|
𝑍=𝐿
= 0          (12) 
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The initial conditions for the column defined as a solute concentration of 0 and a pH of 5 
which is also the pH of the load. 
3.1.2. Affinity Chromatography Parameters 
The physical parameters of the column to be simulated were set to match the manufacturer 
specification of “HiTrap MAb Select SuRe” columns [16]. 
Therefore the average diameter of the particles 𝑑𝑝 was set to 85μm, the column length and 
column diameter were also set to 25mm and 7mm respectively. 
The required empirical parameters for the model were taken from Candy K.S, and others 
article [13]. 
Table 1 Affinity chromatography parameters 
Parameter Symbol Units Value 
Total porosity εT 
 
0.8 
Maximum binding capacity qmax g·L
-1
 73 
Association equilibrium constant KA L·g
-1
 6.1 
Linear isotherm constant H 
 
1.6 
Maximum lumped mass transfer 
coefficient kmax s
-1
 1.6 
Saturation dependent kinetic constant S1 
 
0.26 
Saturation dependent kinetic order S2 
 
4 
pH dependent equilibrium order n  16.6 
 
The AC column is the first column in the purification process, and therefore the only column 
where fresh feed was simulated. The running conditions for the simulation were based on 
Thomas Müller-Spath and Massimo Morbidelli article [7]: 
The feed into this column consist of 0.1 column volumes of a solution with the following 
characteristics: 
 0.4 g/L IgG 
 0.1 g/L Aggregates 
 0.1 g/L Other impurities 
 pH 5 
 0 g/L of Na+ 
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The flow velocity in the column was set to 300 cm/h the concentration of IgG in the feed was 
set to 0.4 g/L the amount of feed loaded into the column was defined as 0.1 CV and the pH 
gradient during the elution was set from 5 after the load to 3 on a linear function over 300 
seconds. 
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3.2. Size exclusion chromatography 
In this work, size exclusion columns were employed in the purification process to stabilize 
and increase the pH from the AC column to the CIEX column and to reduce the salt 
concentration after the CIEX. 
3.2.1. Size Exclusion Chromatography Model 
The size exclusion columns were also modelled by means of a dispersion model. The main 
difference between the size exclusion column and the other kinds modelled (IEX and AC) is 
that there is no adsorption occurring in the column. This means that the separation is purely 
based on the total porosity of the column for each component and rate of diffusion into the 
particles. 
Since the model used in this project for the size exclusion is dispersion model that means 
homogeneous concentration in the radial axis is assumed. The dispersion equation describing 
the model follows: 
𝜕𝐶
𝜕𝑡
= 𝐷𝐿
𝜕2𝐶
𝜕𝑧2
−
𝑣
𝜀𝑇
𝜕𝐶
𝜕𝑧
         (13) 
It’s important to note that in this model that even though the column void is the same for all 
components the total porosity is different for each one as the packing porosity is also varying. 
This is done in order to reflect that the smaller particles can also get inside the particles 
whereas the bigger particles cannot. 
Similarly to the affinity chromatography the boundary conditions for the model are set to no-
flux (Von Neuman) to the right end, and Dirichlet condition on the left end, so the 
concentration of each component on the boundary are set to the values of the feed. 
𝐶|𝑍=0 = 𝐶𝑓𝑒𝑒𝑑         (14) 
𝜕𝐶
𝜕𝑡
|
𝑍=𝑍
= 0          (15) 
The initial conditions are set as an absence of solutes and a pH of 7, which is inside the 
working range for this kind of column [3-12]. 
3.2.2. Size Exclusion Chromatography Parameters 
For this column the physical parameters are set to match those of “Superdex 200 Increase 
10/300 GL” specified by the manufacturer [18].  That is a column length of 300mm, a column 
diameter of 16mm and an averaged particle diameter of 8.6μm. 
The void volume of the column was assumed as 0.3 of the total volume. And the packing 
porosity was also set to different values for each component. 
The packing porosity for the IgG was assumed to 0.2 since it has a molecular weight of 
150kDa it should not be able to diffuse properly into the pores. 
For the first impurity considered which the molecules are smaller than IgG this value was 
estimated to 0.6. 
The third impurity was meant as the molecules bigger than IgG such as dimer and other 
oligomers formed as a result of the aggregation, for that case the packing porosity was set to 
0.15 as they shouldn’t be able to enter the particles properly. 
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Lastly the packing porosity for the Na
+
 and H
+
 ions was set to 1 as these are expected to small 
enough to diffuse into all the pores present in the particles of this column. 
The flow rate speed was set to the optimum flow rate defined by the manufacturer [18] of 
57cm/hr. 
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3.3. Ion Exchange 
Ion exchange chromatography is a method that allows the separation of components based on 
ionic interactions. This technique of separation can be used as long as we are treating with 
charged particles. 
Due to the low and high pI of IgG respective forms this method of purification can be used as 
IgG does require neither too low pH values to be positively charged nor too high pH values to 
be negatively or positively charged. 
3.3.1. Cationic Ion Exchange 
The anionic exchange column was modelled by means of a dispersion model. The proposed 
model is a lumped kinetic model [19]. The kinetic equation for the column follows: 
𝜕𝐶
𝜕𝑡
= 𝐷𝑎𝑥𝑝
𝜕2𝐶
𝜕𝑧2
−
𝑣
𝜀𝑇
𝜕𝐶
𝜕𝑧
−
1−𝜀𝑇
𝜀𝑇
𝜕𝑞
𝜕𝑡
       (16) 
A linear driving force is assumed for the mass transfer i.e. a constant lumped mass transfer 
coefficient "𝑘𝑚" is used in the equation that describes the adsorption. 
𝜕𝑞
𝜕𝑡
= 𝑘𝑚(𝑞𝑖
∗ − 𝑞𝑖)         (17) 
The adsorption equilibrium curve is defined by competitive Langmuir isotherm. 
𝑞∗ =
𝐻𝑖·𝐶𝑖
1+∑
𝐻𝑖
𝑞𝑠𝑎𝑡,𝑖
·𝐶𝑖
𝑛
𝑖=1
         (18) 
The Henry coefficients are defined as a power function based on the salt concentration [19]. 
𝐻𝑖 = 𝛼1,𝑖 · 𝑐𝑠𝑎𝑙𝑡
𝛼2,𝑖          (19) 
As in the other columns the boundary conditions were defined as a no-flux boundary 
condition on the right end of the column and a Dirichlet condition on the other end where the 
concentration in that boundary is set to the concentration of the feed to the column. 
𝐶|𝑍=0 = 𝐶𝑓𝑒𝑒𝑑         (20) 
𝜕𝐶
𝜕𝑡
|
𝑍=𝑍
= 0          (21) 
The initial conditions for the column defined as an initial concentration of 𝑁𝑎+ of 0.0025 mol 
L
-1
 and a pH of 6. 
3.3.2. Cationic Ion Exchange Parameters 
The column physical parameters were taken from the data provided by the manufacturer of 
“POROS HS 50” columns [21]. That is a column length of 10cm, a column diameter of 1.2 
cm and an average particle diameter of 50μm. 
The porosity, mass transfer and Henry coefficients found by T.Müller-Späth et al. [19] are set 
as: 
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Table 2 CIEX paramters 
Parameter Symbol Units Value 
Porosity for IgG and impurities εT 
 
0.58 
Mass transfer coefficient kM min
-1
 3.3 
Saturation capacity qsat g·L
-1
 110 
 
Table 3 CIEX Henry coefficients 
Component α1 α2 
IgG 94708 -6.34 
Impurity 1 312000 -6.34 
Impurity 2 6660 -6.34 
NaCl 2 0 
 
The concentration of salt in the load was defined as 0.0025 mol L
-1 
after the load is finished 
the salt gradient starts, that is linear increase from 0.0025 to 0.25 mol L
-1
 over 600 seconds. 
The flow rate of the column was set to 300cm/hr. 
3.3.3. Anionic ion exchange 
The anionic exchange column was modelled by means of a dispersion model. As we had no 
information about the adsorption occurring in the column, the model was simplified to that of 
a size exclusion column i.e. no adsorption effects are being considered. 
𝜕𝐶
𝜕𝑡
= 𝐷𝐿
𝜕2𝐶
𝜕𝑧2
−
𝑣
𝜀𝑇
𝜕𝐶
𝜕𝑧
         (22) 
The boundary and initial conditions are defined as in the other size exclusion column 
columns. 
𝐶|𝑍=0 = 𝐶𝑓𝑒𝑒𝑑         (23) 
𝜕𝐶
𝜕𝑡
|
𝑍=𝑍
= 0          (24) 
The initial conditions for the column defined as an absence of solutes and a pH of 6. 
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3.3.4. Anionic Ion Exchange Parameters 
The column physical parameters are the same that the ones used for the size exclusion column 
but the packing porosity is set to lower for the IgG, Na
+
, H
+
 and higher for the impurities, this 
is to represent the effect of the impurities binding to the column while the IgG is supposed to 
flow through. 
The difference in a flow through simulation is that since the product leaves first the entire 
outlet of the column is collected as part of the pool until the concentration of impurities 
reaches a certain value. 
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3.4. Alternative models 
An interesting alternative to the mentioned method would be to implement heterogeneous 
model for packed beds which would take into account the effect of diffusion into the particles. 
𝜕𝐶
𝜕𝑡
= 𝐷𝑎𝑥
𝜕2𝐶
𝜕𝑧2
−
𝑣
𝜀𝑐
𝜕𝐶
𝜕𝑧
−
1−𝜀𝑐
𝜀𝑐
3
𝑅𝑝
𝑘 (𝐶 − 𝐶𝑝|𝑟=𝑅𝑝)     (25) 
𝜕𝐶𝑝
𝜕𝑡
=
𝐷
𝜀𝑝
(
𝜕2𝐶𝑝
𝜕𝑟2
+
2
𝑟
𝜕𝐶𝑝
𝜕𝑟
)        (26) 
Note that this model uses dispersion coefficient instead of the apparent dispersion coefficient, 
and packing porosity instead of total porosity. 
With the following boundary conditions: 
𝐶|𝑍=0 = 𝐶𝑓𝑒𝑒𝑑         (27) 
𝜕𝐶
𝜕𝑡
|
𝑍=𝑍
= 0          (28) 
𝜕𝐶𝑝
𝜕𝑟
|
𝑟=0
= 0          (29) 
𝜕𝐶𝑝
𝜕𝑟
|
𝑟=𝑅𝑝
= 𝑘 (𝐶 − 𝐶𝑝|𝑟=𝑅𝑝)        (30) 
This model offers a more realistic description of the process in the packed bed and would be 
especially interesting to implement as an alternative to the current SEC model since in the 
SEC there is no adsorption happening and the separation is based only on the different rate of 
diffusion into the column particles. 
However model adds complexity and drastically increases calculation times since the total 
number of mesh points employed in the finite volume method is equal to the number of mesh 
points in the column multiplied by the number of mesh points in the particles. 
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3.5. Connections between columns 
3.5.1. Pool definition 
After each column only a part of the outflow is taken and loaded into the next column while 
the rest of the outflow is thrown away. The part that is to be loaded into the next column is the 
pool. Since the different steps of the setup have different purposes three different pool types 
were defined, all of them based on Niklas Andersson simplexpooling function. 
3.5.1.1. Pool based on main component purity 
This is the pool used for affinity chromatography and Ion exchange steps. Here a required 
purity of the objective component IgG is set. The pool is the larger amount of outflow that can 
fulfil that purity requirement. 
 
Figure 3 Purity pool example 
3.5.1.2. Pool based on pH 
After the affinity chromatography step the outflow has a very acidic pH (around 3), therefore 
a size exclusion column follows previous to the ion exchange step. 
The main purpose of this column is to set the pH value to that required by the following 
Cationic Ion exchange column, which is pH 6. 
The cationic ion exchange is dependent on the pH on the pool region should also be stable. 
After this step a pool is performed with the objective of obtaining the desired pH, the impurity 
for this pool is defined as the absolute value of the difference between the concentration of H
+
 
ions and the concentration of H
+
 ions at pH 6. 
𝑝𝑜𝑜𝑙𝑖𝑚𝑝 = |𝐶𝐻+ − 10
−6|        (31) 
3.5.1.3. Pool based on salt concentration 
Similarly to the previous after the ion exchange column another size exclusion column 
follows in order to reduce the salt content. In this type the impurity is defined as the salt 
content.  
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3.5.2. Load definition 
As explained before the setup to be studied consists of a series of chromatography columns. 
The initial feed flow goes into the first column and then a pool of the outflow of this first 
column is fed into the second column continuously. This process is repeated until the last 
column. 
As a result of this the inflow or into all the columns (excluding the first one), will have the 
shape of different “peaks” for each component as a result of the chromatographic separation 
in the previous column. Figure 4 shows the outflow of the first AC column as an example. 
 
Figure 4 AC IgG outflow 
In Matlab environment the data of each component outflow comes in the form of discretised 
concentration values of each component for each time value. 
Since this data was to be used in the simulation of the following column it had to be 
interpolated into a continuous function that was named load function. 
For this problem four different interpolation methods were studied, those were: Polynomial 
interpolation, Piecewise linear interpolation (Linear spline), Piecewise polynomial 
interpolation (cubic spline) and Gaussian functions with multiple terms. 
3.5.2.1. Polynomial Interpolation: 
This is a well-known method of interpolation. It consists of interpolating the data to a function 
of the form of: 
𝑓(𝑥) = 𝑎0 + 𝑎1𝑥
1 + 𝑎2𝑥
2 + ⋯ + 𝑎𝑛𝑥
𝑛      (32) 
The higher the n value is, the better fit is to be expected, but this will also increase 
calculations time, therefore it’s recommended to keep this value as low as possible. 
The generic curve show before was interpolated for the main component using polynomial 
interpolations with different “n” values. 
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Figure 5 Polynomial interpolation 
The figure shows the interpolation with different grade equations. It can be observed that 
lower grade polynomial interpolation offer a bad fitting but higher grade polynomial 
interpolation also show a strong effect of Runge’s phenomenon, that is oscillation at the edges 
of an interval. 
3.5.2.2. Linear spline 
One way to avoid this Runge’s phenomenon is the use of spline interpolation. Spline 
interpolation uses a function for each time interval. The simplest case of spline interpolation is 
linear spline interpolation. It has the form of: 
𝑓(𝑥) =  𝑎00 + 𝑎01𝑥     𝑖𝑓 𝑥 ∈ [𝑥0, 𝑥1]       
𝑓(𝑥) =  𝑎10 + 𝑎11𝑥     𝑖𝑓 𝑥 ∈ [𝑥1, 𝑥2]       
… 
𝑓(𝑥) =  𝑎𝑛0 + 𝑎𝑛1𝑥     𝑖𝑓 𝑥 ∈ [𝑥𝑛, 𝑥𝑛+1]      (33) 
When using this kind of interpolation a better fit is obtained: 
21 
 
 
Figure 6 Linear interpolation 
Even though the R
2
 of this kind of interpolation is the maximum R
2
=1 this is not to be 
interpreted as an indicator of the “goodness” of the fitting since by definition spline is forced 
to pass through all the data points but the fit is not perfect as it can be seen with a more on 
detail figure. 
 
Figure 7 Lspline detail 
As it can be seen the fit is not ideal since the area below the curve which is a crucial 
parameter (the total amount of component) might not be properly defined. 
3.5.2.3. Cubic spline 
This interpolation is similar to the linear spline; it is based on the same idea i.e. using 
different functions for each segment but in this case. This offers a best fit than linear spline 
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but it is also unaffected by Runge’s phenomenon and it is still faster to calculate than very 
high degree polynomial interpolations. 
 
Figure 8 Cubic spline 
This method used functions of the form: 
𝑓(𝑥) =  𝑎𝑖0 + 𝑎𝑖1𝑥 + 𝑎𝑖2𝑥
2 + 𝑎𝑖3𝑥
3     𝑖𝑓 𝑥 ∈ [𝑥𝑛, 𝑥𝑛+1]    (34) 
In the detail view it can be see that this kind of interpolation offers a curve that bends to the 
point giving a smoother and better fit. See figure 9 
 
Figure 9 Cubic spline detail 
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3.5.2.4. Gaussian function 
The last method of interpolation which was tested was using Gaussian functions with multiple 
terms. The Gaussian curves might give a good fit to the peaks as long as they are symmetric. 
The advantages of using a Gaussian curve is that it helps to mitigate the effects of noise and 
are useful to predict the curve evolution if only a few points are known, but this offer no 
advantage in the current situation since the results of simulation are not affected by noise and 
do not require extrapolation. 
A one term Gaussian function has the form of: 
𝑓(𝑥) = 𝑎 exp (−
(𝑥−𝑏)2
2𝑐2
)        (35) 
The result can be seen in the following figure: 
 
Figure 10 Gaussian function 
 
It can be seen that a bad fit is obtained with a R
2
 of 0.975 
A fit to three term Gaussian function was also performed, which has the form of: 
  
𝑓(𝑥) = 𝑎1 exp (−
(𝑥−𝑏1)
2
2𝑐1
2 ) + 𝑎2 exp (−
(𝑥−𝑏2)
2
2𝑐2
2 ) + 𝑎3 exp (−
(𝑥−𝑏3)
2
2𝑐3
2 )  (36) 
The result is: 
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Figure 11 Three term Gaussian function 
It can be observed that the fit is significantly better and the R
2
 of this example curve can be 
calculated to 0.996 
3.5.2.5. Implementation 
After the evaluation of the different interpolation methods it was decided to adopt the cubic 
spline as an interpolation method for the load function definition. This method was chosen 
since it does not suffer the same oscillation effect than a polynomial interpolation and it offers 
better fit than a linear spline, and a Gaussian fit. Also the benefits of employing a Gaussian 
curve (noise reduction and better extrapolation) are not expected to be useful in this case. 
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4. Results and discussion 
All the different models were solved using the finite volume and Matlab® ode15s function. 
Also a three point central approximation and a two point backward approximation were used 
for the first and second order derivatives discretization respectively. 
4.1. First step (AC) 
As stated before, the first step in the purification and hence the first step in the calculation 
process is an affinity column. At this step is expected to provide good separation of the IgG 
from the small impurities but not from the aggregates. 
 
Figure 22 AC chromatogram 
As the aggregates are not at separated from IgG the pooling on this step is based on the 
amount of other impurities. This are set to a maximum of 0.05 the concentration of IgG in the 
pool. That produces a pool with the following concentrations (if it were to be homogeneously 
mixed). 
Table 4 AC pool concentration 
 
Concentration g/𝐿 
IgG 0.0356 
Aggregates 0.0089 
Other 
impurities 
0.0023 
 
As expected this step provides very good separation of IgG from a range of the impurities, 
while keeping IgG productivity high. The IgG yield from this step was calculated to 0.9992. 
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In order to plot everything in the same plot the pH value was scaled down 100 times, a closer 
look can show how the pH gradient enhances the elution of the different components. 
 
Figure 13 AC chromatogram detail 
  
27 
 
4.2. Second step (SEC) 
This step is included to stabilize the pH of the solution that is to be loaded to the next column. 
As it could be seen from previous column, the pool obtained from this column has a pH in the 
range from 5 to 4. That load would provide bad conditions for the CIEX column as the pH 
would affect the binding to the column. 
The purpose of this column is to “displace” the pH gradient from the IgG peak. The column is 
initially loaded with a solution at pH 6 and the separation can be achieved through size 
exclusion chromatography as the H
+
 are expected to elute later than the other components 
since they can go through more space in the column due to their much smaller size. 
 
Figure 14 Size exclusion chromatogram 
As it can be seen in the previous figure, the increase in H
+
 concentration that represent a pH 
drop is displaced from the IgG concentration peak. This of course assumes that H
+ 
ions 
behave as larger molecules do in a size exclusion bed which might not be strictly true. 
As a side effect the elution volume is greatly increase due to the length of the column (30cm) 
and the slow flow rate compared to the other chromatographic methods. 
As the pH gradient has been significantly displaced the pool is capable of containing the 
totality of the IgG. This means that they yield of IgG in this purification step is ~1. 
However the concentration of all the components drop equally, since the elution volume has 
increase largely as a result of the dispersion in method that uses a much larger column (30cm) 
with slower flow rate than the other chromatographic methods. 
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4.3. Third step (CIEX) 
The cationic chromatography purification step follows. Here, IgG is expected to bind first at 
low salt buffer conditions and then elute with the salt gradient. The pH of the feed solution is 
now adequate, since a varying pH might induce variations in the binding of to the column. 
First this was simulated using a salt concentration on the initial buffer of 0.05, which lead to 
improper separation of the different components: 
 
Figure 15 CIEX chromatogram 1 
As it can be observed from fig 15 the high volume of load combined with relatively high 
initial buffer led to the components eluding even before the load had ended. This result in 
improper purification as the products elude at the same time. 
In order to avoid so the simulation was set to more strongly binding conditions i.e. an initial 
salt buffer of 0.0025 mol/L Na
+
. 
 
Figure 16 CIEX chromatogram 2 
From this last figure it can be see that a high percentage of the aggregates can be pooled 
away, and almost the totality of the other impurities can be eliminated. The reason for the 
aggregates not being able to separate completely is probably due to the fact that these might 
be positively charged similarly to the IgG at pH 6 conditions. 
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An interesting effect of this purification step is that the aggregates and other impurities peaks 
switch their respective positions towards the IgG peak. In contrast to the other methods the 
aggregates now elute later whereas the other impurities elute earlier. 
As the following columns (SEC, and AIEX in flow through mode) might displace the “other 
impurities” peak to the right (longer elution times than IgG), they are to be effectively 
removed in this step. 
Therefore the pooling requirements for this step were defined as 0.97 purity of IgG, and a 
limit of 0.005 of the non-aggregate impurities. The obtained yield of IgG was 0.952 and the 
pool elution time was reduced 588 seconds. 
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4.4. Forth step (SEC) 
As explained in the introduction the forth step is another size exclusion chromatography 
column but this one yields a different purpose. Instead of stabilizing the pH which is already 
6, this column is meant to eliminate the salt content in the pool. 
Similarly to the H
+
 ions, Na
+
 ions should be separated from the IgG in a size exclusion 
column. 
However a negative effect from the SEC column is to be expected as the aggregates might 
have shorter residence time than the IgG, and therefore elute closer than they did in the 
previous CIEX step. 
 
Figure 17 Second SEC column chromatogram 
As expected the salt gradient can be effectively separated whereas the aggregates peak is 
slightly moved towards the centre of the IgG peak. 
The pool for this step was defined so that the concentration of salt in the pool would be lower 
than 5.6·10
-4
. The yield of IgG was 0.9993 and the elution time was equal to 1052 seconds. 
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4.5. Last step (AIEX) 
The last step consists of an anionic ion exchange column running in flow through mode but as 
explained in the mathematical modelling section it is simplified to the model of a SEC, with 
modified parameters. 
The idea behind the AIEX in flow through mode is that the IgG might elude first whereas the 
aggregates and impurities are retained. 
 
Figure 18 Anionic ion exchange chromatogram 
This results in a reasonably good separation. The pool is performed so that the concentration 
of aggregates in the pool is 0.0001. 
The defined pool elution time is 897 and the obtained yield of IgG is 0.9. The concentration 
of the different components in the pool is: 
Table 5 Purification results 
 
Concentration g/L % of total 
IgG 0.0011 90.8% 
Aggregates 0.0001 8.25% 
Other 
impurities 
0.0000115 0.95% 
Salt 0.000001 0.01% 
 
The yield of IgG produced from the entire purification process can be described as: 
𝑌𝑖𝑒𝑙𝑑𝑡𝑜𝑡𝑎𝑙 = 𝑌𝑖𝑒𝑙𝑑𝑆𝑡𝑒𝑝1 · 𝑌𝑖𝑒𝑙𝑑𝑆𝑡𝑒𝑝2 · 𝑌𝑖𝑒𝑙𝑑𝑆𝑡𝑒𝑝3 · 𝑌𝑖𝑒𝑙𝑑𝑆𝑡𝑒𝑝4 · 𝑌𝑖𝑒𝑙𝑑𝑆𝑡𝑒𝑝5 = 0.856 (37) 
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4.6. Further work 
There are several points from where this project could be further developed, the most 
interesting option would be: 
4.6.1. Process optimization 
There are several parameters that could be optimized; first the pH and salt buffers and 
gradients could be optimized for either most yield or highest purity. 
Also a multivariable optimization could be performed being the purity requirements on each 
step the variables and total yield of IgG the objective. 
4.6.2. Adopting an heterogeneous model 
As mentioned in the alternatives to the mathematical models, a general model could be useful 
to implement especially for the size exclusion chromatography, as it might provide more 
accurate results. 
4.6.3. Develop the first SEC to resemble a virus deactivation step 
It was mentioned that a virus deactivation step usually follows the affinity chromatography, 
that is because a virus deactivation step requires a long residence time~1h at low pH~3. This 
step is not modelled but the first size exclusion column could be modified to accomplish this 
requirements. 
4.6.4. Scale up 
The simulation is developed around lab-scale parameters from bibliography. The work could 
be scaled up to design an industrial production level purification. 
4.6.5. Add mixing tanks in the process 
In the current process there some steps where the position of the different concentration peaks 
change position. This happens in the steps before and after the cationic ion exchange column. 
Adding a continuous stirred tank (CSTR) before the CIEX might increase the separation in 
this step on the other hand adding a CSTR after the CIEX might increase the separation in the 
following steps.  
This might however increase the overall time consumed by the process so effect on 
productivity should also be studied. 
4.6.6. Developing anion exchange model 
The anion exchange column was modelled as a modified size exclusion column, since the 
effect of adsorption into this column was unknown. Developing and implementing an anionic 
exchange model would provide more accurate results. 
4.6.7. Modelling aggregation effects 
As it was previously mentioned, aggregate formation is not implemented in the simulation. 
An initial concentration of aggregates is assumed in the first load instead. It would be 
interesting to model the effect of aggregates in the different chromatographic columns as well 
as the effect during the pumping of product from one column to another. 
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5. Conclusion 
 The purification process was successfully modelled and the results showed an IgG 
purity of 90.8% and yield of 0.856. 
 Size exclusion columns proved an effective method to stabilize the pH gradient and 
remove the salt content. 
 Some steps separate the components in different directions. In the first SEC column 
the aggregates elute faster than the IgG whereas in the following CIEX aggregates 
elute later. Adding a mixing step between the two columns instead of a continuous 
feed from one to the other is to be considered. 
 The anionic ion exchange step provides a separation of IgG from its aggregates worse 
than it was expected. Implementing a more accurate model is probably required for 
better results.  
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7. Appendices 
Table of symbols 
Latin symbols 
Symbol Definition Unit 
C Concentration g/L 
t Time s 
Daxp Apparent axial dispersion coefficient cm^2/s 
L Characteristic Length cm 
km Lumped mass transfer coefficient 1/s 
q Adsorbed solute g/L 
q* Adsorbed solute at equilibrium g/L 
kmax Maximum lumped mass transfer coefficient 1/s 
S1 Saturation dependent kinetic constant  
S2 Saturation dependent kinetic order  
qmax Maximum binding capacity g/L 
qmaxR Maximum binding capacity of all the retained solutes g/L 
qR Sum of all the retained solutes concentrations in the stationary phase g/L 
qsat Saturation capacity g/L 
H Henry coefficient  
KA Association equilibrium constant L/g 
z Spatial dimension z cm 
n Ph dependet equilibrium order  
Rp Particle radius cm 
k Mass transfer coefficient cm/s 
anm Interpolation coefficients  
a,b,c Gaussian interpolation coefficients  
   
Greek symbols 
Symbol Definition Unit 
ν Velocity cm/s 
ε Porosity  
α1 Empirical constant for Henry function  
α2 Empirical constant for Henry function  
 
